Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy.

Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, Yoshimura S, Iwama T.

Cytotherapy. 2011 Jul;13(6):675-85. doi: 10.3109/14653249.2010.549122. Epub 2011 Jan 13.

PMID:
21231804
2.

Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice.

Song M, Mohamad O, Gu X, Wei L, Yu SP.

Cell Transplant. 2013;22(11):2001-15. doi: 10.3727/096368912X657909. Epub 2012 Oct 12.

PMID:
23069268
3.

Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration.

Hiwatashi N, Hirano S, Mizuta M, Tateya I, Kanemaru S, Nakamura T, Ito J.

Laryngoscope. 2014 Dec;124(12):E461-9. doi: 10.1002/lary.24816. Epub 2014 Jul 10.

4.
5.

Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke.

Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdán S, Díez-Tejedor E.

Stem Cell Res Ther. 2013 Jan 28;4(1):11. doi: 10.1186/scrt159.

6.

Transcriptomics comparison between porcine adipose and bone marrow mesenchymal stem cells during in vitro osteogenic and adipogenic differentiation.

Monaco E, Bionaz M, Rodriguez-Zas S, Hurley WL, Wheeler MB.

PLoS One. 2012;7(3):e32481. doi: 10.1371/journal.pone.0032481. Epub 2012 Mar 7.

8.

Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.

Wei N, Yu SP, Gu X, Taylor TM, Song D, Liu XF, Wei L.

Cell Transplant. 2013;22(6):977-91. doi: 10.3727/096368912X657251. Epub 2012 Oct 2.

PMID:
23031629
9.

Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats.

Tsai MJ, Tsai SK, Hu BR, Liou DY, Huang SL, Huang MC, Huang WC, Cheng H, Huang SS.

J Biomed Sci. 2014 Jan 22;21:5. doi: 10.1186/1423-0127-21-5.

10.

Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.

Li CY, Wu XY, Tong JB, Yang XX, Zhao JL, Zheng QF, Zhao GB, Ma ZJ.

Stem Cell Res Ther. 2015 Apr 13;6:55. doi: 10.1186/s13287-015-0066-5.

11.

Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model.

Ghazavi H, Hoseini SJ, Ebrahimzadeh-Bideskan A, Mashkani B, Mehri S, Ghorbani A, Sadri K, Mahdipour E, Ghasemi F, Forouzanfar F, Hoseini A, Pasdar AR, Sadeghnia HR, Ghayour-Mobarhan M.

Stem Cell Rev. 2017 Oct;13(5):670-685. doi: 10.1007/s12015-017-9755-z.

PMID:
28795363
12.

Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.

Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, Liu D, Lin F.

J Transl Med. 2011 Jul 6;9:105. doi: 10.1186/1479-5876-9-105.

13.

The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions.

Kimura K, Nagano M, Salazar G, Yamashita T, Tsuboi I, Mishima H, Matsushita S, Sato F, Yamagata K, Ohneda O.

Stem Cells Dev. 2014 Mar 1;23(5):488-501. doi: 10.1089/scd.2013.0307. Epub 2013 Dec 14.

14.

The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke.

He B, Yao Q, Liang Z, Lin J, Xie Y, Li S, Wu G, Yang Z, Xu P.

Cell Transplant. 2016 Dec 13;25(12):2173-2185. doi: 10.3727/096368916X692627. Epub 2016 Aug 1.

PMID:
27480476
15.

Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.

Díez-Tejedor E, Gutiérrez-Fernández M, Martínez-Sánchez P, Rodríguez-Frutos B, Ruiz-Ares G, Lara ML, Gimeno BF.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2694-700. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.011. Epub 2014 Oct 7.

PMID:
25304723
16.

Expression of cytokines in rat brain with focal cerebral ischemia after grafting with bone marrow stromal cells and endothelial progenitor cells.

He XY, Chen ZZ, Cai YQ, Xu G, Shang JH, Kou SB, Li M, Zhang HT, Duan CZ, Zhang SZ, Ke YQ, Zeng YJ, Xu RX, Jiang XD.

Cytotherapy. 2011 Jan;13(1):46-53. doi: 10.3109/14653249.2010.510505. Epub 2010 Aug 24.

PMID:
20735164
17.

Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.

Cui X, Chen J, Zacharek A, Li Y, Roberts C, Kapke A, Savant-Bhonsale S, Chopp M.

Stem Cells. 2007 Nov;25(11):2777-85. Epub 2007 Jul 19.

18.

Angiogenesis following cell injection is induced by an excess inflammatory response coordinated by bone marrow cells.

Hattori H, Amano Y, Habu-Ogawa Y, Ando T, Takase B, Ishihara M.

Cell Transplant. 2013;22(12):2381-92. doi: 10.3727/096368912X658863. Epub 2012 Nov 8.

PMID:
23146336
19.

Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.

Chen J, Yang Y, Shen L, Ding W, Chen X, Wu E, Cai K, Wang G.

Cell Mol Neurobiol. 2017 Aug;37(6):1115-1129. doi: 10.1007/s10571-016-0445-1. Epub 2016 Nov 18.

PMID:
27858286
20.

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.

Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2542-7. Epub 2005 Oct 13.

PMID:
16224047

Supplemental Content

Support Center